Let’s answer some common myths about ketamine therapy with facts.
Myth: Ketamine causes addiction like other street drugs.
Fact: In a clinical setting under medical supervision, ketamine has a low potential for addiction. Treatments are carefully monitored and scheduled to prevent dependency.
Myth: Ketamine treatment is just a quick fix.
Fact: Although ketamine provides rapid symptom relief, it is often part of a comprehensive treatment plan that includes therapy and lifestyle changes to sustain mental health improvements.
Myth: Ketamine can only help with depression.
Fact: Research supports ketamine’s effectiveness in treating a range of conditions, including anxiety, PTSD, and certain chronic pain syndromes, thereby broadening its therapeutic reach.
Myth: Ketamine therapy is experimental and unregulated.
Fact: IV Ketamine therapy follows strict medical guidelines. Its use for depression is off-label, but it is not experimental. The FDA’s approval of esketamine (nasal form of ketamine) provides an additional layer of validation.
Myth: You can easily get ketamine treatments at any clinic.
Fact: Only clinics with specialized medical staff trained in its use for mental health disorders can and should offer legitimate ketamine treatments.
Myth: Ketamine therapy is prohibitively expensive and not covered by insurance.
Fact: Esketamine (Spravato), the nasal spray form of ketamine, is often covered by insurance for treatment-resistant depression, making it more accessible. However, keep in mind, not all ketamine treatment therapies are the same.
Myth: All forms of ketamine are the same.
Fact: Ketamine is available in various forms, each with different methods of administration and bioavailability. Intravenous (IV) ketamine and the nasal spray form (esketamine) are the most common in clinical settings for treating depression and other mood disorders, but they differ significantly:
- Intravenous (IV) Ketamine: Offers nearly 100% bioavailability, meaning it is fully absorbed and utilized by the body, providing the quickest and most effective results.
- Nasal Spray (Esketamine): Has about 48% bioavailability, which is significantly lower than IV administration. However, its non-invasive nature and insurance coverage makes it a option for patients.
Myth: Ketamine has severe psychological side effects.
Fact: Most side effects, such as dissociation or elevated blood pressure, are temporary and closely monitored during the treatment session.
By addressing these common myths about ketamine therapy, We want you to have a clear understanding and reassurance about its role as a potential treatment option for your mental health struggles. We understand that choosing a treatment path is a significant decision filled with many considerations. If you have more questions or would like to explore how ketamine therapy might benefit you personally, we encourage you to reach out. We offer free consultations to discuss your specific circumstances, address any concerns, and help determine if ketamine therapy would be right for you. Please reach out to start a conversation that could lead to significant improvements in your mental health and overall quality of life.
Hear from Tara and how this therapy helped her anxiety especially in social situations.